Anurag Thakur seeks bulk drug park establishment in Himachal Pradesh, meets Mandaviya
New Delhi: Union Information and Broadcasting Minister Anurag Thakur on Tuesday met Chemical and Fertiliser, and Health Minister Mansukh Mandaviya with a request to set up one of the three bulk drug parks, planned by the government, in Himachal Pradesh.
He also requested Mandaviya to fast-track the development of a satellite centre of the Post Graduate Institute of Medical Education and Research, Chandigarh, at Una in Himachal Pradesh.
Thakur said setting up a bulk drug park in Himachal will give a boost to the pharmaceutical industry in the state and create 10,000 jobs.
In the Union Budget, the Centre had allocated Rs 3,000 crore for setting up three bulk drug parks.
Thakur said he also requested Mandaviya to speed up the development of the satellite centre of PGIMER, Chandigarh, at Malahat in the Una district.
Read also: CM Jairam Thakur seeks Centre to sanction Bulk Drug Pharma Park for Himachal Pradesh
He said Rs 500 crore has been sanctioned for the satellite centre and the foundation stone for the same was laid in 2019.
The residents of Punjab and Himachal Pradesh will benefit from the satellite centre which will also create employment opportunities in the region, Thakur said.
Assembly elections are due in Himachal Pradesh later this year.
Medical Dialogues had earlier reported that Union Minister Mansukh Mandaviya had exhorted the champions, leaders of the Pharmaceutical Industry and had discussed the roadmap for the Indian pharmaceutical sector.
"Let us move from 'Volume' to "Value' leadership to capture global pharmaceutical market. It is time to accumulate knowledge from global best practices in research, manufacturing and innovation and develop our own models focused on accelerating production to meet the domestic demand while increasing our global footprint," Union Minister for Chemicals and Fertilizers and Health and Family Welfare, Mansukh Mandaviya had said at the interactive session with Indian Pharmaceutical Alliance.
Read also: Union Health Minister discusses roadmap for Indian pharma sector
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.